These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6782042)

  • 1. Liposomal encapsulated Zn-DTPA for removing intracellular 169Yb.
    Blank ML; Cress EA; Byrd BL; Washburn LC; Snyder F
    Health Phys; 1980 Dec; 39(6):913-20. PubMed ID: 6782042
    [No Abstract]   [Full Text] [Related]  

  • 2. Liposomal preparations of calcium- or zinc-DTPA have a high efficacy for removing colloidal Ytterbium-169 from rat tissues.
    Blank ML; Byrd BL; Cress EA; Washburn LC; Snyder F
    Toxicology; 1984 Apr; 30(4):275-81. PubMed ID: 6729826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular plutonium: removal by liposome-encapsulated chelating agent.
    Rahman YE; Rosenthal MW; Cerny EA
    Science; 1973 Apr; 180(4083):300-2. PubMed ID: 4633691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delivery of DTPA through Liposomes as a Good Strategy for Enhancing Plutonium Decorporation Regardless of Treatment Regimen.
    Grémy O; Miccoli L; Lelan F; Bohand S; Cherel M; Mougin-Degraef M
    Radiat Res; 2018 May; 189(5):477-489. PubMed ID: 29528770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of DTPA entrapped in conventional and long-circulating liposomes of different size for plutonium decorporation.
    Phan G; Herbet A; Cholet S; Benech H; Deverre JR; Fattal E
    J Control Release; 2005 Dec; 110(1):177-88. PubMed ID: 16257469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 169Yb-DTPA distribution and dosimetry in cisternography.
    Morin RL; Brookeman VA
    J Nucl Med; 1974 Sep; 15(9):786-96. PubMed ID: 4408395
    [No Abstract]   [Full Text] [Related]  

  • 7. [Penetration of 169Yb-citrate through intact and abraded skins].
    Zhu SP; Wang CD; Cao GF; Wang GL
    Zhongguo Yao Li Xue Bao; 1984 Dec; 5(4):288-9. PubMed ID: 6240909
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of Zn-DTPA and Ca-DTPA in removing plutonium from the human body.
    Ohlenschläger L; Schieferdecker H; Schmidt-Martin W
    Health Phys; 1978 Nov; 35(5):694-9. PubMed ID: 744734
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of liposome-encapsulated pentacin on plutonium-239 excretion].
    Il'in LA; Ivannikov AT; Altukhova GA; Parfenova IM; Chelysheva TV
    Radiobiologiia; 1989; 29(2):197-201. PubMed ID: 2717714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of drinking Zn-DTPA on 238-Pu and 241-Am in rat bones.
    Volf V
    Radiat Environ Biophys; 1984; 23(2):141-3. PubMed ID: 6739717
    [No Abstract]   [Full Text] [Related]  

  • 11. [Efficacy of polymeric 239Pu removal by liposome-encapsulated pentacin].
    Smirnov AA; Altukhova GA; Beliaev IK; Ivannikov AT; Il'in LA
    Radiobiologiia; 1984; 24(3):386-9. PubMed ID: 6739746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acceleration of the excretion of monomeric 239Pu-citrate from the body as effected by pentacyne encapsulated in liposomes].
    Il'in LA; Smirnov AA; Ivannikov AT; Parfenova IM
    Vopr Med Khim; 1983; 29(4):109-12. PubMed ID: 6353751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decorporation of inhaled plutonium nitrate from hamsters using Zn-DTPA.
    Stradling GN; Stather JW; Sumner SA; Strong JC; Lennox AM; Ham SE
    Health Phys; 1984 Apr; 46(4):919-24. PubMed ID: 6706599
    [No Abstract]   [Full Text] [Related]  

  • 14. [Plutonium-329 metabolic characteristics during the separate and combined administration of an iron preparation and DTPA].
    Shvydko NS; Rushonik SI; Popov DK; Likhtarev IA
    Radiobiologiia; 1981; 21(6):868-72. PubMed ID: 7323274
    [No Abstract]   [Full Text] [Related]  

  • 15. [Liposomal polycarboxylic chelating agents for elimination of toxic metals from the body].
    Muzia GI; Kulikov VI
    Vestn Akad Med Nauk SSSR; 1990; (8):30-3. PubMed ID: 2125777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Autoradiographic visualization of the retention of 169Yb-citrate in bone and its removal by drugs (author's transl)].
    Chu SP; Jiang J
    Zhongguo Yao Li Xue Bao; 1981 Mar; 2(1):64-6. PubMed ID: 6461205
    [No Abstract]   [Full Text] [Related]  

  • 17. [Body retention of 169Yb-citrate and its excretion by 4 chelating agents].
    Zhu SP; Zhao JY; Su KY; Mo QZ; Wang GL
    Zhongguo Yao Li Xue Bao; 1984 Dec; 5(4):285-8. PubMed ID: 6240908
    [No Abstract]   [Full Text] [Related]  

  • 18. Removal of plutonium from beagles using Ca-DTPA and Zn-DTPA: effects on initial DTPA injection.
    Taylor GN; Lloyd RD; Boseman JJ; Atherton DR; Mays CW
    Health Phys; 1978 Aug; 35(2):201-10. PubMed ID: 701016
    [No Abstract]   [Full Text] [Related]  

  • 19. The use of Ca-DTPA as a treatment for plutonium inhaled in mixed oxide aerosols of plutonium and sodium.
    Stather JW; Rodwell P
    Health Phys; 1980 Nov; 39(5):801-5. PubMed ID: 7204032
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of ethylenediaminetetraacetic acid (EDTA) and diethylenetriaminepentaacetic acid (DTPA) derivatives on penetration of ytterbium-169 and cerium-144 into the rat offspring.
    Baltrukiewicz Z; Burakowski T; Derecki J
    Acta Physiol Pol; 1976; 27(2):175-81. PubMed ID: 818876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.